tiprankstipranks
Trending News
More News >
Medartis Holding AG (CH:MED)
:MED
Switzerland Market
Advertisement

Medartis Holding AG (MED) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

MED Analyst Ratings

Hold
1Ratings
Hold
0 Buy
1 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Medartis
Holding AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MED Stock 12 Month Forecast

Average Price Target

CHF90.00
▼(-1.85% Downside)
Based on 1 Wall Street analysts offering 12 month price targets for Medartis Holding AG in the last 3 months. The average price target is CHF90.00 with a high forecast of CHF90.00 and a low forecast of CHF90.00. The average price target represents a -1.85% change from the last price of CHF91.70.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"52":"CHF52","91":"CHF91","61.75":"CHF61.8","71.5":"CHF71.5","81.25":"CHF81.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF90.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF90.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF90.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[52,61.75,71.5,81.25,91],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,86.4,86.67692307692309,86.95384615384616,87.23076923076924,87.50769230769231,87.78461538461539,88.06153846153846,88.33846153846154,88.61538461538461,88.8923076923077,89.16923076923077,89.44615384615385,89.72307692307692,{"y":90,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,86.4,86.67692307692309,86.95384615384616,87.23076923076924,87.50769230769231,87.78461538461539,88.06153846153846,88.33846153846154,88.61538461538461,88.8923076923077,89.16923076923077,89.44615384615385,89.72307692307692,{"y":90,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,86.4,86.67692307692309,86.95384615384616,87.23076923076924,87.50769230769231,87.78461538461539,88.06153846153846,88.33846153846154,88.61538461538461,88.8923076923077,89.16923076923077,89.44615384615385,89.72307692307692,{"y":90,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":76.5,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":68.4,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":75,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":61.7,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":57.2,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":56.2,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53.8,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":56.6,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":69.5,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":73.9,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":73.9,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.3,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF90.00Average Price TargetCHF90.00Lowest Price TargetCHF90.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS
CHF90
Hold
-1.85%
Downside
Reiterated
08/20/25
Medartis Holding AG (MED) Receives a Hold from UBS
TR | OpenAI - 4o Analyst forecast on CH:MED
TR | OpenAI - 4o
TR | OpenAI - 4o
CHF77CHF87
Hold
-5.13%
Downside
Reiterated
08/20/25
AI Generated ArticleAI Generated Article
Stifel Nicolaus Analyst forecast on CH:MED
Stifel Nicolaus
Stifel Nicolaus
CHF86
Buy
-6.22%
Downside
Reiterated
03/24/25
Positive Outlook for Medartis Holding AG: Strategic Initiatives and Financial Projections Support Buy Rating
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS
CHF90
Hold
-1.85%
Downside
Reiterated
08/20/25
Medartis Holding AG (MED) Receives a Hold from UBS
TR | OpenAI - 4o Analyst forecast on CH:MED
TR | OpenAI - 4o
TR | OpenAI - 4o
CHF77CHF87
Hold
-5.13%
Downside
Reiterated
08/20/25
AI Generated ArticleAI Generated Article
Stifel Nicolaus Analyst forecast on CH:MED
Stifel Nicolaus
Stifel Nicolaus
CHF86
Buy
-6.22%
Downside
Reiterated
03/24/25
Positive Outlook for Medartis Holding AG: Strategic Initiatives and Financial Projections Support Buy Rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medartis Holding AG

1 Month
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+3.40%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +3.40% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+3.70%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +3.70% per trade.
1 Year
Dylan Van HaaftenStifel Nicolaus
Success Rate
1/1 ratings generated profit
100%
Average Return
+25.90%
reiterated a buy rating 6 months ago
Copying Dylan Van Haaften's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.90% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+25.90%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +25.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MED Analyst Recommendation Trends

Rating
Mar 25
Jul 25
Aug 25
Strong Buy
0
0
0
Buy
2
7
7
Hold
0
1
4
Sell
0
0
0
Strong Sell
0
0
0
total
2
8
11
In the current month, MED has received 7 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. MED average Analyst price target in the past 3 months is 90.00.
Each month's total comprises the sum of three months' worth of ratings.

MED Financial Forecast

MED Earnings Forecast

The previous quarter’s earnings for MED were -CHF0.12.
The previous quarter’s earnings for MED were -CHF0.12.

MED Sales Forecast

Next quarter’s sales forecast for MED is CHF143.70M with a range of CHF143.70M to CHF143.70M. The previous quarter’s sales results were CHF123.04M. MED beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.40% of the time in the same period. In the last calendar year MED has Preformed in-line its overall industry.
Next quarter’s sales forecast for MED is CHF143.70M with a range of CHF143.70M to CHF143.70M. The previous quarter’s sales results were CHF123.04M. MED beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.40% of the time in the same period. In the last calendar year MED has Preformed in-line its overall industry.

MED Stock Forecast FAQ

What is CH:MED’s average 12-month price target, according to analysts?
Based on analyst ratings, Medartis Holding AG’s 12-month average price target is 90.00.
    What is CH:MED’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:MED, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Medartis Holding AG a Buy, Sell or Hold?
        Medartis Holding AG has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Medartis Holding AG’s share price target?
          The average share price target for Medartis Holding AG is 90.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF90.00 ,and the lowest forecast is CHF90.00. The average share price target represents -1.85% Decrease from the current price of CHF91.7.
            What do analysts say about Medartis Holding AG?
            Medartis Holding AG’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
              How can I buy shares of Medartis Holding AG?
              To buy shares of CH:MED, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis